Rifabutin-Loaded Nanostructured Lipid Carriers as a Tool in Oral Anti-Mycobacterial Treatment of Crohn’s Disease

Oral anti-mycobacterial treatment of Crohn’s disease (CD) is limited by the low aqueous solubility of drugs, along with the altered gut conditions of patients, making uncommon their clinical use. Hence, the aim of the present work is focused on the in vitro evaluation of rifabutin (RFB)-loaded Nanos...

Descripción completa

Detalles Bibliográficos
Autores principales: Rouco, Helena, Diaz-Rodriguez, Patricia, Gaspar, Diana P., Gonçalves, Lídia M. D., Cuerva, Miguel, Remuñán-López, Carmen, Almeida, António J., Landin, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692220/
https://www.ncbi.nlm.nih.gov/pubmed/33121030
http://dx.doi.org/10.3390/nano10112138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692220/
https://www.ncbi.nlm.nih.gov/pubmed/33121030
http://dx.doi.org/10.3390/nano10112138

Ejemplares similares